| |
 |
|
Class Information
Number: 514/233.8
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) > Morpholines (i.e., fully hydrogenated 1,4- oxazines) > Additional hetero ring attached directly or indirectly to the morpholine ring by nonionic bonding > Polycyclo ring system having the additional hetero ring as one of the cyclos > Bicyclo ring system having the additional hetero ring as one of the cyclos > Plural ring hetero atoms in the bicyclo ring system
Description: Subject matter in which the bicyclo ring system contains two or more ring hetero atoms.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 8710048 |
6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling |
Apr. 29, 2014 |
| 8680090 |
Sulfonyl containing benzothiazole inhibitors of endothelial lipase |
Mar. 25, 2014 |
| 8637508 |
Heterocyclic derivatives and their use in the treatment of neurological disorders |
Jan. 28, 2014 |
| 8609655 |
Calcimimetic compound for use in the treatment of epithelial injury |
Dec. 17, 2013 |
| 8586579 |
Anellated pyridine compounds |
Nov. 19, 2013 |
| 8557811 |
Dual-color imaging method of sodium/calcium activities using two-photon fluorescent probes and preparation method of two-photon fluorescent probes |
Oct. 15, 2013 |
| 8551982 |
Benzodioxane inhibitors of leukotriene production |
Oct. 8, 2013 |
| 8536166 |
Inhibitors of Burton's tyrosine kinase |
Sep. 17, 2013 |
| 8518970 |
Compounds and methods of use |
Aug. 27, 2013 |
| 8507483 |
1H-pyrimidin-2-one derivatives, preparation thereof and pharmaceutical use thereof as inhibitors of AKT (PKB) phosphorylation |
Aug. 13, 2013 |
| 8481532 |
PDE-10 inhibitors |
Jul. 9, 2013 |
| 8470817 |
Compounds and methods for treatment of cancer |
Jun. 25, 2013 |
| 8470850 |
Inhibitors of VEGF receptor and HGF receptor signalling |
Jun. 25, 2013 |
| 8461156 |
Modulators of ATP-binding cassette transporters |
Jun. 11, 2013 |
| 8455484 |
Selected inhibitors of protein tyrosine kinase activity |
Jun. 4, 2013 |
| 8445480 |
CETP inhibitors derived from benzoxazole arylamides |
May. 21, 2013 |
| 8445488 |
Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitors |
May. 21, 2013 |
| 8410109 |
Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
Apr. 2, 2013 |
| 8389517 |
Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular disease |
Mar. 5, 2013 |
| 8389516 |
Antibacterial compositions |
Mar. 5, 2013 |
| 8377921 |
Compounds and compositions as protein kinase inhibitors |
Feb. 19, 2013 |
| 8343954 |
Compositions and methods for inhibition of the JAK pathway |
Jan. 1, 2013 |
| 8329726 |
Inhibitors of VEGF receptor and HGF receptor signaling |
Dec. 11, 2012 |
| 8324200 |
Compositions and methods for inhibition of the JAK pathway |
Dec. 4, 2012 |
| 8324204 |
Fused thiophene derivatives as kinase inhibitors |
Dec. 4, 2012 |
| 8318733 |
Modulators of ATP-binding cassette transporters |
Nov. 27, 2012 |
| 8314121 |
Imidazolone derivatives, preparation thereof as drugs, pharmaceutical compositions, and use thereof as protein kinase inhibitors, in particular CDC7 |
Nov. 20, 2012 |
| 8293769 |
CSF-1R inhibitors, compositions, and methods of use |
Oct. 23, 2012 |
| 8288380 |
Thiophenediamine derivative having urea structure |
Oct. 16, 2012 |
| 8283344 |
Method of treating inherited severe neutropenia |
Oct. 9, 2012 |
| 8273736 |
Thienopyridine and furopyridine kinase inhibitors |
Sep. 25, 2012 |
| 8247412 |
Urea derivatives methods for their manufacture and uses thereof |
Aug. 21, 2012 |
| 8232273 |
Heterocyclic compounds and methods of use |
Jul. 31, 2012 |
| 8198271 |
Thiophenediamine derivative having urea structure |
Jun. 12, 2012 |
| 8198316 |
Process for the preparation of 5,6 -dihydro -4H-4(S)-ethylamino-6(S)-methylthieno[2,3-b] thiopyran-2-sulfonamide- 7,7 -dioxide and its salt |
Jun. 12, 2012 |
| 8188078 |
6-aryl/heteroalkyloxy benzothiazole and benzimidazole derivatives, method for preparing same, application thereof as drugs, pharmaceutical compositions and novel use in particular as C-MET inh |
May. 29, 2012 |
| 8173649 |
Glucokinase activator |
May. 8, 2012 |
| 8163742 |
Di-amino-substituted heterocyclic compounds and methods of use |
Apr. 24, 2012 |
| 8129410 |
Benzisoxazole piperidine compounds and methods of use thereof |
Mar. 6, 2012 |
| 8114893 |
Compounds and methods of use |
Feb. 14, 2012 |
| 8110571 |
Benzimidazole and benzothiazole derivatives, method for preparing same, use thereof as drugs, pharmaceutical compositions and novel use especially as c-MET inhibitors |
Feb. 7, 2012 |
| 8110572 |
Inhibitors of protein kinases |
Feb. 7, 2012 |
| 8106048 |
Heterocyclic NF-.kappa.B inhibitors |
Jan. 31, 2012 |
| 8106069 |
Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors and pharmaceutical compositions comprising them |
Jan. 31, 2012 |
| 8097610 |
Derivative having PPAR agonistic activity |
Jan. 17, 2012 |
| 8088766 |
Cyanoguanidines and cyanoamidines as ErbB2 and EGFR inhibitors |
Jan. 3, 2012 |
| 8053433 |
Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors |
Nov. 8, 2011 |
| 8003617 |
Methods of treating diabetes mellitus |
Aug. 23, 2011 |
| 7994164 |
Mineralocorticoid receptor antagonists and methods of use |
Aug. 9, 2011 |
| 7985749 |
Compounds and compositions as cathepsin S inhibitors |
Jul. 26, 2011 |
|
|
|
